80 related articles for article (PubMed ID: 7876326)
1. Nongenomic regulation of extracellular matrix events by vitamin D metabolites.
Boyan BD; Dean DD; Sylvia VL; Schwartz Z
J Cell Biochem; 1994 Nov; 56(3):331-9. PubMed ID: 7876326
[TBL] [Abstract][Full Text] [Related]
2. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
3. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
4. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms.
Boyan BD; Dean DD; Sylvia VL; Schwartz Z
Connect Tissue Res; 2003; 44 Suppl 1():130-5. PubMed ID: 12952186
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes.
Schwartz Z; Sylvia VL; Curry D; Luna MH; Dean DD; Boyan BD
Endocrinology; 1999 Jul; 140(7):2991-3002. PubMed ID: 10385391
[TBL] [Abstract][Full Text] [Related]
8. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C.
Nemere I; Schwartz Z; Pedrozo H; Sylvia VL; Dean DD; Boyan BD
J Bone Miner Res; 1998 Sep; 13(9):1353-9. PubMed ID: 9738506
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
[TBL] [Abstract][Full Text] [Related]
10. Nongenomic regulation of protein kinase C isoforms by the vitamin D metabolites 1 alpha,25-(OH)2D3 and 24R,25-(OH)2D3.
Sylvia VL; Schwartz Z; Ellis EB; Helm SH; Gomez R; Dean DD; Boyan BD
J Cell Physiol; 1996 Jun; 167(3):380-93. PubMed ID: 8655592
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts.
Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z
Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216
[TBL] [Abstract][Full Text] [Related]
12. 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2.
Boyan BD; Sylvia VL; Dean DD; Pedrozo H; Del Toro F; Nemere I; Posner GH; Schwartz Z
Steroids; 1999; 64(1-2):129-36. PubMed ID: 10323681
[TBL] [Abstract][Full Text] [Related]
13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
14. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
[TBL] [Abstract][Full Text] [Related]
15. 24,25-(OH)2D3 regulation of matrix vesicle protein kinase C occurs both during biosynthesis and in the extracellular matrix.
Sylvia VL; Schwartz Z; Holmes SC; Dean DD; Boyan BD
Calcif Tissue Int; 1997 Oct; 61(4):313-21. PubMed ID: 9312202
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies on the regulation of endochondral ossification by vitamin D.
Boyan BD; Schwartz Z; Swain LD
Crit Rev Oral Biol Med; 1992; 3(1-2):15-30. PubMed ID: 1730069
[TBL] [Abstract][Full Text] [Related]
17. Nongenomic regulation of chondrocyte membrane fluidity by 1,25-(OH)2D3 and 24,25-(OH)2D3 is dependent on cell maturation.
Swain LD; Schwartz Z; Caulfield K; Brooks BP; Boyan BD
Bone; 1993; 14(4):609-17. PubMed ID: 8274303
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.
Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z
Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979
[TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
20. Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.
Boyan BD; Schwartz Z; Park-Snyder S; Dean DD; Yang F; Twardzik D; Bonewald LF
J Biol Chem; 1994 Nov; 269(45):28374-81. PubMed ID: 7961777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
